PRVA · Privia Health Group, Inc.
$25.50
+0.53 (+2.12%)
At close · Jul 24
Market Cap
$3.21B
Shares
126.01M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-07 | 2026-07-06 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-22 | 2026-05-20 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-02 | 2026-05-20 | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-12-08 | 2025-12-05 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-28 | 2025-10-24 | |
| 8-K | 2025-09-23 | — | |
| 8-K | 2025-08-29 | 2025-08-28 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-08 | 2025-07-03 | |
| 8-K | 2025-05-22 | 2025-05-21 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-04 | 2025-05-21 | |
| 8-K | 2025-03-07 | 2025-03-03 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-03 | 2024-07-01 | |
| 8-K | 2024-06-05 | — | |
| 8-K/A | 2024-05-29 | 2024-05-22 | |
| 8-K | 2024-05-23 | 2024-05-22 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-04 | 2024-05-22 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-29 | 2024-01-25 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-21 | 2023-11-16 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-31 | — | |
| 8-K | 2023-06-29 | 2023-06-23 | |
| 8-K | 2023-05-25 | 2023-05-24 | |
| 8-K | 2023-05-10 | 2023-05-09 | |
| 8-K | 2023-05-08 | 2023-05-04 |
Showing 1–50 of 92 filings
Key facts
CIK
1759655
CUSIP
74276R102
13F (30d)
48 filings
48 filers
Visit website
Investor relations